On the contrary, studies in colon cancer cells showed that either pharmacological inhibition or siRNA-mediated knockdown of GSK3β augmented TZD-induced reduction of NFκB activity, cell growth inhibition and apoptosis induction [43]. The gene discussed is GSK3B; the disease is colonic neoplasm.